Beyond Ozempic: Why Silicon Valley Is Turning to Experimental Peptides
Jasmine Sun on unregulated peptides moving from fringe biohacking to Silicon Valley mainstream, promising healing, focus, and optimization with little oversight
More Videos
Elon Musk’s Tesla and SpaceX Hit by Post-Election Selloff
Elon Musk’s business empire is facing renewed pressure as Tesla and SpaceX shares extend their losses following the Democrats’ midterm victories.
OpenAI Faces Backlash Over Massive A.I. Data Centers
OpenAI is launching a campaign to win over communities increasingly frustrated with the rapid expansion of artificial intelligence data centers.
Wendy’s Fights Off $1.4 Billion Takeover
Wendy’s is fighting to stay independent after rejecting a $1.4 billion takeover offer from billionaire investor Nelson Peltz and his partners.
Amazon Prime Teams Up with Uber Eats
Amazon is teaming up with Uber Eats to give Prime members another major perk.
Wall Street Meltdown, DOW Crashes 1,800 Points
Wall Street’s post-election celebration has turned into a massive selloff.
Beyond Data Centers: The Heavy Machinery Powering AI
Custom Truck One Source CEO Ryan McMonagle explains how AI data centers and power grid upgrades are fueling equipment demand as rental revenue jumps 20% higher.
